The use of contrast-enhanced ultrasound (CEUS) has been widely reported for reproductive imaging in humans and animals. This review aims to analyze the utility of CEUS in characterizing canine reproductive physiology and pathologies. In September 2022, a search for articles about CEUS in canine testicles, prostate, uterus, placenta, and mammary glands was conducted on PubMed and Scopus from 1990 to 2022, showing 36 total results. CEUS differentiated testicular abnormalities and neoplastic lesions, but it could not characterize tumors. In prostatic diseases, CEUS in dogs was widely studied in animal models for prostatic cancer treatment. In veterinary medicine, this diagnostic tool could distinguish prostatic adenocarcinomas. In ovaries, CEUS differentiated the follicular phases. In CEH-pyometra syndrome, it showed a different enhancement between endometrium and cysts, and highlighted angiogenesis. CEUS was shown to be safe in pregnant dogs and was able to assess normal and abnormal fetal–maternal blood flow and placental dysfunction. In normal mammary glands, CEUS showed vascularization only in diestrus, with differences between mammary glands. CEUS was not specific for neoplastic versus non-neoplastic masses and for benign tumors, except for complex carcinomas and neoplastic vascularization. Works on CEUS showed its usefulness in a wide spectrum of pathologies of this non-invasive, reliable diagnostic procedure.

The aim of this study was to assess the beneficial effects of oral supplementation of Lepidium meyenii (Maca) on improving and keeping sperm quality in dogs during storage, and to investigate its effect on changes in testosterone concentrations. Forty male dogs were enrolled in the study and divided into four groups of ten dogs each: two subfertile (control and treatment) and two normofertile (control and treatment) groups. The dogs in the treatment groups received Maca in a capsule formulation (75 mg/kg), while the control groups received placebo. The spermiogram and testosterone levels were assessed at three times of the sperm cycle: 0 (T0), 31 (T31), and 62 (T62) days. Ejaculates were processed for storage at 5 °C and evaluated for total and progressive motility and membrane integrity at 3 (T3h), 24 (T24h), 48 (T48h), and 72 h (T72h) post storage. The oral supplementation of 75 mg/kg of Maca extract in dogs can improve sperm parameters and increase serum testosterone concentrations, leading to improved reproductive capacity. The semen of subjects treated with oral Maca supplementation maintained its parameters stable for a longer period when stored compared to the semen of control subjects, demonstrating the beneficial effect of the use of this extract on male fertility.

The prostate is the only sexual gland of the male dog, and dihydrotestosterone (DHT) regulates its growth. In intact dogs, constant DHT stimulation results in benign prostatic hyperplasia (BPH) that can be treated with osaterone acetate (OSA). This study describes the effects of OSA treatment, detected by contrast-enhanced ultrasonography (CEUS), highlighting prostatic vascularization with a contrast agent composed of gas microbubbles. Fifteen dogs (2–8 years) of different sizes and breeds (4–30 kg) diagnosed with BPH are involved in the study. Before treatment (D₀), CPSE is measured (294.05 ± 115.97 ng/mL), and a B-mode ultrasound is performed (Vratio = 2.80 ± 1.85), confirming BPH. CEUS highlights the length of the wash-in (11.93 ± 2.08 s) and wash-out (42.20 ± 6.99 s) phases of the contrast agent in the prostate and the presence of cysts and parenchymal alteration. Dogs are treated with OSA (0.5 mg/kg for 7 days) and reassessed after 21 days (D₁): CPSE and prostate volume are significantly (p < 0.001) reduced. The length of the wash-in (14.73 ± 2.54 s) and wash-out (51.13 ± 6.03 s) phases are significantly (p < 0.001) increased. The results confirm the effectiveness of the treatment, particularly the reduction in prostatic perfusion, confirmed by the increase in diffusion times of the contrast. Although preliminary, these findings are promising for the use of CEUS in monitoring dogs with BPH.

The gestation period in ferrets lasts 42 days (range 38–42). Numerous cases of maternal and paternal cannibalism have been reported, so it is important for breeders to know the exact date of parturition in order to separate the mother from the other ferrets in the herd. Fetal ultrasonographic biometry and specific formulae for assessing fetal growth have not yet been developed in ferrets as they have been in dogs and cats. The aim of this study was to develop a formula, similar to those available for other domestic species, that could be used in ferrets to date the birth of a litter to within one day. Among the different ultrasonographic parameters, the biparietal diameter (BP) gave a very accurate prediction and showed a significant relationship with days before parturition. The formula developed could allow better planning of care before, during and after parturition, thus helping to reduce neonatal mortality.